Navigation Links
Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business
Date:2/25/2008

Approvals include CONFIENT(TM) ICD, LIVIAN(TM) CRT-D and upgraded

LATITUDE(R) Patient Management System

NATICK, Mass., Feb. 25 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval for three products in its Cardiac Rhythm Management business. They are:

-- The CONFIENT(TM) implantable cardioverter defibrillator (ICD), which

helps protect patients at risk of sudden cardiac death

-- The LIVIAN(TM) cardiac resynchronization therapy defibrillator

(CRT-D), which provides cardiac resynchronization and defibrillation

therapies in one device

-- An upgraded LATITUDE(R) Patient Management System, with enhanced

remote monitoring capabilities

"Our Cardiac Rhythm Management (CRM) team is refocused on delivering therapy systems that meet physicians' needs for safety, reliability and better patient outcomes," said Jim Tobin, President and Chief Executive Officer of Boston Scientific. "These and other recent approvals are tangible examples of the team's revitalized commitment to quality and innovation."

CONFIENT ICD

The CONFIENT ICD features an enhanced AV (atrial ventricular) Search Hysteresis feature designed to reduce unnecessary right ventricular pacing. The device is equipped with wireless capability designed to save physicians time during implant by allowing device programming during wound closure and eliminating the need for the programming wand in the sterile field. Wireless capability also saves time at follow-up visits by offering device interrogations that can be three times faster than the Company's wanded telemetry.

LIVIAN CRT-D

The
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
2. Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007
3. Boston Scientific to Participate in Merrill Lynch Conference
4. CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium
5. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
6. Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program
7. Boston Scientific Announces Results for Third Quarter Ended September 30, 2007
8. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
9. The 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Nov. 2-6
10. Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator
11. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... "The interface is the device," Nobel laureate Herbert ... to be found at the junctures where layers ... of nanotechnology, the interfaces between layers of metal ... such high-tech favorites as spintronics, high-temperature superconductors, ferroelectrics ...
(Date:1/15/2014)... The Pittcon Organizing Committee is pleased to announce ... , an e-Journal and producer of Food Labs ... year for the co-location of Food Labs Conference to be ... the registration fee to attend the two-day Food Lab Conference, ...
(Date:1/15/2014)... January 15, 2014 Look inside the ... items for the lab, from fluid handling to instruments ... to ship when you order. , Preferred Solutions ... , from the L/S® model for precise flow control ...
(Date:1/15/2014)... and SAN JOSE, California , ... biotechnology company developing antibody-drug conjugates for cancer, today announced the ... of Directors. Dr Reynolds has over 20 years, development experience ... Officer at Seattle Genetics. "I am delighted to ...
Breaking Biology Technology:A deeper look at interfaces 2Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3
... Sergio Lopez , 18, of Kyle, Texas , recently underwent a ... surgery to repair a broken bone in his arm that would not heal. ... device, such as a screw or plate. It,s this implantation that deterred Lopez ... , "I ...
... ,, HAIKOU CITY, China , ... CPHI ) ("China Pharma" or the "Company"), a leading,fully-integrated specialty pharmaceuticals company ... President, Ms. Zhilin Li , has,been invited to be a speaker ... Sciences Summit. , , , ...
... May 13 Repligen Corporation (Nasdaq: RGEN ... Drug Application (IND) with the Food and Drug Administration (FDA) ... deacetylase 3 (HDAC-3) inhibitor.  This is a double-blind, single ascending ... pharmacokinetic and safety profile of RG2833 in up to 40 ...
Cached Biology Technology:Texas Teen Opts for Stem Cell Therapy, Hopes of Enlisting in Military 2Texas Teen Opts for Stem Cell Therapy, Hopes of Enlisting in Military 3China Pharma Holdings, Inc. CEO to Speak at Brean Murray, Carret & Co. 2010 Life Sciences Summit 2China Pharma Holdings, Inc. CEO to Speak at Brean Murray, Carret & Co. 2010 Life Sciences Summit 3China Pharma Holdings, Inc. CEO to Speak at Brean Murray, Carret & Co. 2010 Life Sciences Summit 4Repligen Files Investigational New Drug Application with FDA for First Drug Targeting the Core Genetic Defect of Friedreich's Ataxia 2Repligen Files Investigational New Drug Application with FDA for First Drug Targeting the Core Genetic Defect of Friedreich's Ataxia 3Repligen Files Investigational New Drug Application with FDA for First Drug Targeting the Core Genetic Defect of Friedreich's Ataxia 4
(Date:4/23/2014)... -- Researchers have found evidence of an interaction ... increase aggressive behavior in children, especially in girls. ... children exposed to prenatal smoking will have behavioral ... said Brian Boutwell, Assistant Professor at Sam Houston ... author on the study. "One possible explanation ...
(Date:4/23/2014)... from using triclosan as an antimicrobial ingredient in soaps, ... scientists are reporting new evidence that appears to support ... Chemical Research in Toxicology , found that triclosan, ... the growth of human breast cancer cells in lab ... Choi and colleagues note that hormonal imbalances seem to ...
(Date:4/23/2014)... the family of bacteria that causes whooping cough ... surprising findings about the bacteria,s origin and evolution. ... to control this respiratory disease, which kills 195,000 ... 343 strains of the Bordetella pertussis ... last 100 years illustrates how vaccination has shaped ...
Breaking Biology News(10 mins):Genetics risk, prenatal smoking may predict behavioral problems 2In lab tests, the antimicrobial ingredient triclosan spurs growth of breast cancer cells 2Impact of whooping cough vaccination revealed 2
... many neurodegenerative diseases the neurons of the brain are ... failed attempts and much scepticism this process was finally ... treatment in some patients with stroke. But very few ... In a new highly detailed study, researchers have ...
... microbiota in a new-born baby,s gut has been linked to ... week in PLOS Computational Biology . The findings ... the body,s microbial ecosystem - in an infant can influence ... gut of a new-born baby is quickly populated by a ...
... of large-bodied mammals inhabited the "mammoth steppe," a cold and ... northern Asia and across the Bering land bridge to the ... wolves and bears were able to maintain their ranges well ... new study led by researchers at the University of California, ...
Cached Biology News:Researchers discover a missing link in signals contributing to neurodegeneration 2Early infant growth rate linked to composition of gut microbiota 2Dietary flexibility may have helped some large predators survive after last ice age 2Dietary flexibility may have helped some large predators survive after last ice age 3
Kit Components: Anti-PARP LumiGLO Chemiluminescent Substrate Immunoblot Blocking Reagent Pyronin Y Reagent Goat Anti-Rabbit IgG, HRP conjugate Double-It Reagent Film Exposure Folders Autor...
... version of Freezerworks Unlimited includes 2 clients and ... facilitates the sharing of freezers by multiple groups ... Network Client/Server version ... in monitor with 256 colors; OS 8.6 & ...
Polypropylene test tube racks, used in Thermo Forma's line of Test Tube Rack holders...
Mixing speed from 750-3200RPM, small vortexing orbit of1.0mm...
Biology Products: